Elizabeth Hand

786 total citations
15 papers, 663 citations indexed

About

Elizabeth Hand is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Elizabeth Hand has authored 15 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 4 papers in Molecular Biology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Elizabeth Hand's work include Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Platelet Disorders and Treatments (4 papers) and Pharmaceutical studies and practices (4 papers). Elizabeth Hand is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Platelet Disorders and Treatments (4 papers) and Pharmaceutical studies and practices (4 papers). Elizabeth Hand collaborates with scholars based in United States, Chile and Japan. Elizabeth Hand's co-authors include Deborah Panebianco, M Hichens, Hans Deckmyn, Inge De Lepeleire, Jos Vermylen, Kathelijne Peerlinck, E H Ulm, HJ Gomez, Jérôme Biollaz and A. E. Till and has published in prestigious journals such as Circulation, Neurology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Elizabeth Hand

15 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth Hand United States 13 330 140 127 107 70 15 663
B. Kaufmann Germany 14 247 0.7× 86 0.6× 54 0.4× 86 0.8× 27 0.4× 29 650
Silvia Villa Italy 12 174 0.5× 66 0.5× 99 0.8× 47 0.4× 50 0.7× 26 546
Sara Moráis Portugal 10 66 0.2× 252 1.8× 157 1.2× 168 1.6× 50 0.7× 27 921
Stefan Blech Germany 6 450 1.4× 126 0.9× 62 0.5× 120 1.1× 289 4.1× 8 771
Marina De Smet United States 17 188 0.6× 289 2.1× 21 0.2× 132 1.2× 111 1.6× 21 1.1k
Mitsutaka Kanamaru Japan 15 159 0.5× 53 0.4× 30 0.2× 140 1.3× 15 0.2× 44 698
Klaus Moerike Germany 5 146 0.4× 86 0.6× 42 0.3× 105 1.0× 20 0.3× 6 582
Alexander G. Vandell United States 14 364 1.1× 52 0.4× 161 1.3× 144 1.3× 187 2.7× 23 789
P Zech France 14 120 0.4× 89 0.6× 40 0.3× 127 1.2× 8 0.1× 56 749
Siv Jönsson Sweden 18 89 0.3× 57 0.4× 242 1.9× 85 0.8× 58 0.8× 50 901

Countries citing papers authored by Elizabeth Hand

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Hand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Hand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Hand more than expected).

Fields of papers citing papers by Elizabeth Hand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Hand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Hand. The network helps show where Elizabeth Hand may publish in the future.

Co-authorship network of co-authors of Elizabeth Hand

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Hand. A scholar is included among the top collaborators of Elizabeth Hand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Hand. Elizabeth Hand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Hogg, Ronald J., Ángela Delucchi, Thomas G. Wells, et al.. (2007). A multicenter study of the pharmacokinetics of lisinopril in pediatric patients with hypertension. Pediatric Nephrology. 22(5). 695–701. 24 indexed citations
2.
Wells, Thomas G., Ronald J. Hogg, Abdullah Şakarcan, et al.. (2001). The Pharmacokinetics of Enalapril in Children and Infants with Hypertension. The Journal of Clinical Pharmacology. 41(10). 1064–1074. 39 indexed citations
3.
Connor, John D., et al.. (2000). Pharmacokinetic assessment of an oral enalapril suspension for use in children. Biopharmaceutics & Drug Disposition. 21(9). 339–344. 13 indexed citations
4.
Greenberg, Howard, Paul Wissel, Jeffrey Barrett, et al.. (2000). Antiplatelet Effects of MK‐852, a Platelet Fibrinogen Receptor Antagonist, in Healthy Volunteers. The Journal of Clinical Pharmacology. 40(5). 496–507. 23 indexed citations
5.
Ellis, Joan D., Elizabeth Hand, & John D. Gilbert. (1997). Use of LC-MS/MS to cross-validate a radioimmunoassay for the fibrinogen receptor antagonist, Aggrastat (tirofiban hydrochloride) in human plasma. Journal of Pharmaceutical and Biomedical Analysis. 15(5). 561–569. 13 indexed citations
6.
Prueksaritanont, Thomayant, Maria T. Stranieri, Elizabeth Hand, et al.. (1997). Effects of pentobarbital on pharmacokinetics and pharmacodynamics of a potent fibrinogen receptor antagonist, L-734 217, in dogs. Biopharmaceutics & Drug Disposition. 18(8). 649–663. 3 indexed citations
7.
Cook, Jacquelynn J., Gary R. Sitko, Marie A. Holahan, et al.. (1997). Nonpeptide glycoprotein IIb/IIIa inhibitors: 14: oral antithrombotic efficacy of L-738,167 in a conscious canine model of coronary artery electrolytic injury.. PubMed. 96(3). 949–58. 13 indexed citations
8.
Cook, Jacquelynn J., Marie A. Holahan, Denise Ramjit, et al.. (1996). Nonpeptide glycoprotein IIb/IIIa inhibitors. 8. Antiplatelet activity and oral antithrombotic efficacy of L-734,217.. Journal of Pharmacology and Experimental Therapeutics. 278(1). 62–73. 18 indexed citations
9.
Barrett, Jeffrey S., Gail Murphy, Kathelijne Peerlinck, et al.. (1994). Pharmacokinetics and pharmacodynamics of MK-383, a selective non-peptide platelet glycoprotein-IIb/IIIa receptor antagonist, in healthy men. Clinical Pharmacology & Therapeutics. 56(4). 377–388. 111 indexed citations
10.
Hand, Elizabeth, et al.. (1994). Determination of MK-383, a non-peptide fibrinogen receptor antagonist, in human plasma and urine by radioimmunoassay. Journal of Pharmaceutical and Biomedical Analysis. 12(8). 1047–1053. 12 indexed citations
11.
Hand, Elizabeth, M Hichens, Timothy Olah, et al.. (1993). Determination of MK-852, a new fibrinogen receptor antagonist, in plasma and urine by radioimmunoassay. Journal of Pharmaceutical and Biomedical Analysis. 11(6). 427–434. 8 indexed citations
12.
Peerlinck, Kathelijne, Inge De Lepeleire, Michael R. Goldberg, et al.. (1993). MK-383 (L-700,462), a selective nonpeptide platelet glycoprotein IIb/IIIa antagonist, is active in man.. Circulation. 88(4). 1512–1517. 140 indexed citations
13.
14.
Rupniak, N.M.J., Spencer J. Tye, C.A. Jennings, et al.. (1989). Antiparkinsonian efficacy of a novel transdermal delivery system for (+)-PHNO in MPTP-treated squirrel monkeys. Neurology. 39(3). 329–329. 27 indexed citations
15.
Ulm, E H, M Hichens, HJ Gomez, et al.. (1982). Enalapril maleate and a lysine analogue (MK‐521): disposition in man.. British Journal of Clinical Pharmacology. 14(3). 357–362. 182 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. Kaufmann Breakdown of academic impact, for papers by Silvia Villa Breakdown of academic impact, for papers by Sara Moráis Breakdown of academic impact, for papers by Stefan Blech Breakdown of academic impact, for papers by Marina De Smet Breakdown of academic impact, for papers by Mitsutaka Kanamaru Breakdown of academic impact, for papers by Klaus Moerike Breakdown of academic impact, for papers by Alexander G. Vandell Breakdown of academic impact, for papers by P Zech Breakdown of academic impact, for papers by Siv Jönsson
Rankless by CCL
2026